singapore immunology network
Trying Not to Go Viral
Infectious diseases such as dengue and influenza continue to plague the world despite our best efforts to develop vaccines and drugs. Sim Shuzhen takes stock of how scientists are faring in the fight against seemingly indomitable foes.
Curiox & A*STAR Collaborate On Cheaper Multiplexing Assays
Collaborations with the Singapore Immunology Network and the Institute of Molecular and Cell Biology have helped Curiox validate their DropArray technology.
Old Diabetes Drug Takes On New Target
Scientists have found that the drug metformin can indirectly boost existing TB therapy while avoiding drug resistance.
Lipids: The New Target For Cancer Immunotherapy
Lipids, rather than proteins, expressed by leukemia cells are a promising new target for T cell-driven cancer immunotherapy.
S’pore To Study Loss Of Immunity In Elderly
A collaborative effort in Singapore will start a Phase IV clinical trial to understand age-related loss of immunity in the elderly.
Dust Mites Main Cause Of Allergies In S’pore
Researchers have identified house dust mites as the main cause of respiratory allergies in Singapore.
How Golden Staph Breaks Down Our Immune Defenses
A new study shows how golden staph identifies key immune cells and 'nukes' our body's immune response when it enters our skin.
Mode Of Action Of Plerixafor Unraveled
Scientists have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia.
New Anti-Dengue Strategy Raises Hopes For Universal Vaccine
Scientists have come up with a new strategy that cripples the ability of the dengue virus to escape the host immune system.
